GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Microbot Medical Inc (NAS:MBOT) » Definitions » Cyclically Adjusted PB Ratio

Microbot Medical (Microbot Medical) Cyclically Adjusted PB Ratio : 0.04 (As of May. 03, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Microbot Medical Cyclically Adjusted PB Ratio?

As of today (2024-05-03), Microbot Medical's current share price is $0.9798. Microbot Medical's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $27.40. Microbot Medical's Cyclically Adjusted PB Ratio for today is 0.04.

The historical rank and industry rank for Microbot Medical's Cyclically Adjusted PB Ratio or its related term are showing as below:

MBOT' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.19   Max: 0.72
Current: 0.04

During the past years, Microbot Medical's highest Cyclically Adjusted PB Ratio was 0.72. The lowest was 0.01. And the median was 0.19.

MBOT's Cyclically Adjusted PB Ratio is ranked better than
98.92% of 464 companies
in the Medical Devices & Instruments industry
Industry Median: 2.13 vs MBOT: 0.04

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Microbot Medical's adjusted book value per share data for the three months ended in Dec. 2023 was $0.384. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $27.40 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Microbot Medical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Microbot Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbot Medical Cyclically Adjusted PB Ratio Chart

Microbot Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.02 0.07 0.04 0.06

Microbot Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.06 0.03 0.06

Competitive Comparison of Microbot Medical's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Microbot Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbot Medical's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Microbot Medical's Cyclically Adjusted PB Ratio falls into.



Microbot Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Microbot Medical's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.9798/27.4
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbot Medical's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Microbot Medical's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.384/129.4194*129.4194
=0.384

Current CPI (Dec. 2023) = 129.4194.

Microbot Medical Quarterly Data

Book Value per Share CPI Adj_Book
201403 223.853 99.695 290.597
201406 -72.327 100.560 -93.084
201409 371.520 100.428 478.771
201412 138.402 99.070 180.801
201503 -54.839 99.621 -71.242
201506 227.829 100.684 292.852
201509 106.057 100.392 136.723
201512 -2.197 99.792 -2.849
201603 -79.742 100.470 -102.718
201606 -56.262 101.688 -71.605
201609 -17.619 101.861 -22.386
201612 0.958 101.863 1.217
201703 2.141 102.862 2.694
201706 5.428 103.349 6.797
201709 4.559 104.136 5.666
201712 3.683 104.011 4.583
201803 3.173 105.290 3.900
201806 2.572 106.317 3.131
201809 2.039 106.507 2.478
201812 0.442 105.998 0.540
201903 2.142 107.251 2.585
201906 1.853 108.070 2.219
201909 1.486 108.329 1.775
201912 4.389 108.420 5.239
202003 4.178 108.902 4.965
202006 3.997 108.767 4.756
202009 3.725 109.815 4.390
202012 3.420 109.897 4.028
202103 3.141 111.754 3.637
202106 2.830 114.631 3.195
202109 2.514 115.734 2.811
202112 2.023 117.630 2.226
202203 1.635 121.301 1.744
202206 1.201 125.017 1.243
202209 0.778 125.227 0.804
202212 0.924 125.222 0.955
202303 0.596 127.348 0.606
202306 0.809 128.729 0.813
202309 0.628 129.860 0.626
202312 0.384 129.419 0.384

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Microbot Medical  (NAS:MBOT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Microbot Medical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Microbot Medical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbot Medical (Microbot Medical) Business Description

Traded in Other Exchanges
Address
25 Recreation Park Drive, Unit 108, Hingham, MA, USA, 02043
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.
Executives
Rachel Vaknin officer: Chief Financial Officer DROR 3/10, ZICHRON YAAKOV L3 3090216
Simon Sharon officer: General Manager & CTO 8 HAMADA STREET, ZICHRON YAACOV L3 3090708
Yoseph Bornstein director, 10 percent owner 16 IRUS STREET, ROSH HA'AYIN L3 4858022
Tal Baruch Wenderow director 1149, BEACON STREET, NEWTON MA 02461
Eyal Morag officer: Chief Medical Officer BONEY HAEAR 3 STREET, APT #13, TEL AVIV L3 6937303
Aileen Ptucha Stockburger director 26 WELLINGTON CT, BELLE MEADE NJ 08502
Harel Gadot director, 10 percent owner, officer: Chairman and CEO 5 VILLAGE LANE, HINGHAM MA 02043
Joseph Mona 10 percent owner 808 HAMPTON ST, COLUMBIA SC 29201
Prattipati Laxminarain director 3 HEWINS FARM ROAD, WELLESLEY MA 02481
Yoav Zvi Waizer director 8 HAVERED STREET, RAANANA L3 4352308
Moshe Shoham director 22 BEDOLACH STREET, HOSHAYA L3 1791500
Leon Lewkowicz 10 percent owner GORDON STREET 10, APARTMENT 7, TEL-AVIV L3 63458
Martin J. Madden director C/O MICROBOT MEDICAL INC., 175 DERBY STREET 27/1, HINGHAM MA 02043
Yehezkel Himelfarb officer: General Manager & COO 32 BEN YOSEF STREET, TEL-AVIV L3 6912530
Sandra Berkson 10 percent owner C/O SABER HOLDING GMBH, WEIN KRUMMBAUMGASSE C4 1020

Microbot Medical (Microbot Medical) Headlines

From GuruFocus

Microbot Medical Announces Final Data From Its Recent Animal Study

By sperokesalga sperokesalga 05-05-2023

Microbot Medical Expand IP protection in Japan

By Marketwired 06-22-2023